JIC
FLNA

Johnson Investment Counsel’s Filana Therapeutics FLNA Stock Holding History

Johnson Investment Counsel’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
12,000
– – ﹤0.01% 839
2026
Q1 		$20.3K Hold
12,000
– – ﹤0.01% 808
2025
Q4 		$23.8K Hold
12,000
– – ﹤0.01% 788
2025
Q3 		$34.9K Hold
12,000
– – ﹤0.01% 820
2025
Q2 		$21.7K Hold
12,000
– – ﹤0.01% 814
2025
Q1 		$18K Hold
12,000
– – ﹤0.01% 800
2024
Q4 		$28.3K Buy
12,000
+5,000
+71% +$87.8K ﹤0.01% 784
2024
Q3 		$206K Buy
+7,000
New +$161K ﹤0.01% 763

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Johnson Investment Counsel's FLNA Position: Q2 2026 in Review

Johnson Investment Counsel held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 12,000 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #839.

Johnson Investment Counsel first reported a position in FLNA in Q3 2024 and has held it in 8 quarters since. The position peaked at $206K in Q3 2024. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Johnson Investment Counsel held 12,000 shares of Filana Therapeutics worth $14.3K as of Q2 2026.
  • Johnson Investment Counsel left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #839 holding.
  • Johnson Investment Counsel first reported a position in Filana Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Johnson Investment Counsel's Filana Therapeutics position peaked at $206K in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.